We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Growth Hormone Drug industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope
Somatropin Biopartners
Market Segment by Product Application
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Finally, the report provides detailed profile and data information analysis of leading company.
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Growth Hormone Drug consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Growth Hormone Drug market by identifying its various subsegments.
3.Focuses on the key global Growth Hormone Drug manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Growth Hormone Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Growth Hormone Drug submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Growth Hormone Drug Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Growth Hormone Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Growth Hormone Drug Segment by Type
2.1.1 Norditropin
2.1.2 Genotropin
2.1.3 Humatrope
2.1.4 Saizen
2.1.5 Omnitrope
2.1.6 Somatropin Biopartners
2.2 Market Analysis by Application
2.2.1 Prader-Willi Syndrome
2.2.2 Turner Syndrome
2.2.3 Short Stature Homeobox Gene
2.2.4 Small for Gestational Age
2.2.5 Chronic Renal Insufficiency
2.2.6 Short Bowel Syndrome
2.3 Global Growth Hormone Drug Market Comparison by Regions (2017-2027)
2.3.1 Global Growth Hormone Drug Market Size (2017-2027)
2.3.2 North America Growth Hormone Drug Status and Prospect (2017-2027)
2.3.3 Europe Growth Hormone Drug Status and Prospect (2017-2027)
2.3.4 China Growth Hormone Drug Status and Prospect (2017-2027)
2.3.5 Japan Growth Hormone Drug Status and Prospect (2017-2027)
2.3.6 Southeast Asia Growth Hormone Drug Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Growth Hormone Drug Industry Impact
2.5.1 Growth Hormone Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Growth Hormone Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Growth Hormone Drug Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Growth Hormone Drug Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Growth Hormone Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Growth Hormone Drug Manufacturer Market Share
3.5 Top 10 Growth Hormone Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Growth Hormone Drug Market
3.7 Key Manufacturers Growth Hormone Drug Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Growth Hormone Drug Industry Key Manufacturers
4.1 Eli Lilly and Company (US)
4.1.1 Compan Detail
4.1.2 Eli Lilly and Company (US) Growth Hormone Drug Product Introduction, Application and Specification
4.1.3 Eli Lilly and Company (US) 136 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Eli Lilly and Company (US) News
4.2 Ferring Holding SA (Switzerland)
4.2.1 Compan Detail
4.2.2 Ferring Holding SA (Switzerland) Growth Hormone Drug Product Introduction, Application and Specification
4.2.3 Ferring Holding SA (Switzerland) Growth Hormone Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Eli Lilly and Company (US) News
4.3 Genentech, Inc. (US)
4.3.1 Compan Detail
4.3.2 Genentech, Inc. (US) Growth Hormone Drug Product Introduction, Application and Specification
4.3.3 Genentech, Inc. (US) Growth Hormone Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Genentech, Inc. (US) News
4.4 GeneScience Pharmaceuticals Co., Ltd. (China)
4.4.1 Compan Detail
4.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Growth Hormone Drug Product Introduction, Application and Specification
4.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Growth Hormone Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) News
4.5 Merck KgaA (Germany)
4.5.1 Compan Detail
4.5.2 GeneScience Pharmaceuticals Co., Ltd. (China) Growth Hormone Drug Product Introduction, Application and Specification
4.5.3 Merck KgaA (Germany) Growth Hormone Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Merck KgaA (Germany) News
4.6 Novo Nordisk A/S (Denmark)
4.6.1 Compan Detail
4.6.2 Novo Nordisk A/S (Denmark) Growth Hormone Drug Product Introduction, Application and Specification
4.6.3 Novo Nordisk A/S (Denmark) Growth Hormone Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Novo Nordisk A/S (Denmark) News
4.7 Pfizer, Inc. (US)
4.7.1 Compan Detail
4.7.2 Pfizer, Inc. (US) Growth Hormone Drug Product Introduction, Application and Specification
4.7.3 Pfizer, Inc. (US) Growth Hormone Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Sandoz International GmbH (Germany)
4.8.1 Compan Detail
4.8.2 Sandoz International GmbH (Germany) Growth Hormone Drug Product Introduction, Application and Specification
4.8.3 Sandoz International GmbH (Germany) Growth Hormone Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Sandoz International GmbH (Germany) News
5 Global Growth Hormone Drug Market Segment by Big Type
5.1 Global Growth Hormone Drug Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Growth Hormone Drug Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Growth Hormone Drug Revenue and Market Share by Big Type (2017-2022)
5.2 Norditropin Sales Growth Rate and Price
5.2.1 Global Norditropin Sales Growth Rate (2017-2022)
5.2.2 Global Norditropin Price (2017-2022)
5.3 Genotropin Sales Growth Rate and Price
5.3.1 Global Genotropin Sales Growth Rate (2017-2022)
5.3.2 Global Genotropin Price (2017-2022)
5.4 Humatrope Sales Growth Rate and Price
5.4.1 Global Humatrope Sales Growth Rate (2017-2022)
5.4.2 Global Humatrope Price (2017-2022)
5.5 Saizen Sales Growth Rate and Price
5.5.1 Global Saizen Sales Growth Rate (2017-2022)
5.5.2 Global Saizen Price (2017-2022)
5.6 Omnitrope Sales Growth Rate and Price
5.6.1 Global Omnitrope Sales Growth Rate (2017-2022)
5.6.2 Global Omnitrope Price (2017-2022)
5.7 Somatropin Biopartners Sales Growth Rate and Price
5.7.1 Global Somatropin Biopartners Sales Growth Rate (2017-2022)
5.7.2 Global Somatropin Biopartners Price (2017-2022)
6 Global Growth Hormone Drug Market Segment by Big Application
6.1 Global Growth Hormone Drug Sales Market Share by Big Application (2017-2022)
6.2 Prader-Willi Syndrome Sales Growth Rate (2017-2022)
6.3 Turner Syndrome Sales Growth Rate (2017-2022)
6.4 Short Stature Homeobox Gene Sales Growth Rate (2017-2022)
6.5 Small for Gestational Age Sales Growth Rate (2017-2022)
6.6 Chronic Renal Insufficiency Sales Growth Rate (2017-2022)
6.7 Short Bowel Syndrome Sales Growth Rate (2017-2022)
7 Global Growth Hormone Drug Forecast
7.1 Global Growth Hormone Drug Revenue, Sales and Growth Rate (2022-2027)
7.2 Growth Hormone Drug Market Forecast by Regions (2022-2027)
7.2.1 North America Growth Hormone Drug Market Forecast (2022-2027)
7.2.2 Europe Growth Hormone Drug Market Forecast (2022-2027)
7.2.3 China Growth Hormone Drug Market Forecast (2022-2027)
7.2.4 Japan Growth Hormone Drug Market Forecast (2022-2027)
7.2.5 Southeast Asia Growth Hormone Drug Market Forecast (2022-2027)
7.2.6 Other Regions Growth Hormone Drug Market Forecast (2022-2027)
7.3 Growth Hormone Drug Market Forecast by Type (2022-2027)
7.3.1 Global Growth Hormone Drug Sales Forecast by Type (2022-2027)
7.3.2 Global Growth Hormone Drug Market Share Forecast by Type (2022-2027)
7.4 Growth Hormone Drug Market Forecast by Application (2022-2027)
7.4.1 Global Growth Hormone Drug Sales Forecast by Application (2022-2027)
7.4.2 Global Growth Hormone Drug Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Growth Hormone Drug Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Growth Hormone Drug Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Growth Hormone Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Growth Hormone Drug
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Growth Hormone Drug Market Size by Big Type
Figure Global Market Share of Growth Hormone Drug by Big Type in 2021
Figure Norditropin Picture (2017-2022)
Figure Genotropin Picture (2017-2022)
Figure Humatrope Picture (2017-2022)
Figure Saizen Picture (2017-2022)
Figure Omnitrope Picture (2017-2022)
Global Growth Hormone Drug Market Size by Big Application
Table Global Growth Hormone Drug Market Size by Application
Figure Global Growth Hormone Drug Market Share by Big Application in 2021
Figure Prader-Willi Syndrome Picture
Figure Turner Syndrome Picture
Figure Short Stature Homeobox Gene Picture
Figure Small for Gestational Age Picture
Figure Chronic Renal Insufficiency Picture
Figure Short Bowel Syndrome Picture
Table Global Growth Hormone Drug Comparison by Regions (M USD) (2017-2027?
Figure Global Growth Hormone Drug Market Size (Million US$) (2017-2027)
Figure North America Growth Hormone Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Growth Hormone Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure China Growth Hormone Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Growth Hormone Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Growth Hormone Drug Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Growth Hormone Drug Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Growth Hormone Drug Sales by Manufacturer (2017-2022)
Figure Global Growth Hormone Drug Sales Market Share by Manufacturer in 2021
Table Global Growth Hormone Drug Revenue by Manufacturer (2017-2022)
Figure Global Growth Hormone Drug Revenue Market Share by Manufacturer in 2021
Table Global Growth Hormone Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Growth Hormone Drug Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Growth Hormone Drug Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Growth Hormone Drug Market
Table Key Manufacturers Growth Hormone Drug Product Type
Table Mergers & Acquisitions Planning
Table Eli Lilly and Company (US) Company Profile
Table Growth Hormone Drug Product Introduction, Application and Specification of Eli Lilly and Company (US)
Table Growth Hormone Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Ferring Holding SA (Switzerland) Company Profile
Table Growth Hormone Drug Product Introduction, Application and Specification of Ferring Holding SA (Switzerland)
Table Growth Hormone Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ferring Holding SA (Switzerland) Recent Development
Table Genentech, Inc. (US) Company Profile
Table Growth Hormone Drug Product Introduction, Application and Specification of Genentech, Inc. (US)
Table Growth Hormone Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Genentech, Inc. (US) Main Business
Table Genentech, Inc. (US) Recent Development
Table GeneScience Pharmaceuticals Co., Ltd. (China) Company Profile
Table Growth Hormone Drug Product Introduction, Application and Specification of GeneScience Pharmaceuticals Co., Ltd. (China)
Table Growth Hormone Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GeneScience Pharmaceuticals Co., Ltd. (China) Main Business
Table GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development
Table GeneScience Pharmaceuticals Co., Ltd. (China) Main Business
Table GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development
Table Merck KgaA (Germany) Company Profile
Table Growth Hormone Drug Product Introduction, Application and Specification of Merck KgaA (Germany)
Table Growth Hormone Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck KgaA (Germany) Main Business
Table Merck KgaA (Germany) Recent Development
Table Novo Nordisk A/S (Denmark) Company Profile
Table Growth Hormone Drug Product Introduction, Application and Specification of Novo Nordisk A/S (Denmark)
Table Growth Hormone Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novo Nordisk A/S (Denmark) Main Business
Table Novo Nordisk A/S (Denmark) Recent Development
Table Pfizer, Inc. (US) Company Profile
Table Growth Hormone Drug Product Introduction, Application and Specification of Pfizer, Inc. (US)
Table Growth Hormone Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer, Inc. (US) Main Business
Table Pfizer, Inc. (US) Recent Development
Table Sandoz International GmbH (Germany) Company Profile
Table Growth Hormone Drug Product Introduction, Application and Specification of Sandoz International GmbH (Germany)
Table Growth Hormone Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sandoz International GmbH (Germany) Main Business
Table Sandoz International GmbH (Germany) Recent Development
Figure Global Growth Hormone Drug Sales and Growth Rate (2017-2022)
Figure Global Growth Hormone Drug Revenue and Growth Rate (2017-2022)
Table Global Growth Hormone Drug Sales by Regions (2017-2022)
Figure Global Growth Hormone Drug Sales Market Share by Regions in 2021
Table Global Growth Hormone Drug Revenue by Regions (2017-2022)
Figure Global Growth Hormone Drug Revenue Market Share by Regions in 2021
Figure North America Growth Hormone Drug Sales and Growth Rate (2017-2022)
Figure Europe Growth Hormone Drug Sales and Growth Rate (2017-2022)
Figure China Growth Hormone Drug Sales and Growth Rate (2017-2022)
Figure Japan Growth Hormone Drug Sales and Growth Rate (2017-2022)
Figure Southeast Asia Growth Hormone Drug Sales and Growth Rate (2017-2022)
Figure Other Regions Growth Hormone Drug Sales and Growth Rate (2017-2022)
Table Global Growth Hormone Drug Sales by Big Type (2017-2022)
Table Global Growth Hormone Drug Sales Market Share by Big Type (2017-2022)
Figure Global Growth Hormone Drug Sales Market Share by Big Type in 2019
Table Global Growth Hormone Drug Revenue by Big Type (2017-2022)
Table Global Growth Hormone Drug Revenue Market Share by Big Type (2017-2022)
Table Global Growth Hormone Drug Revenue Market Share by Big Type in 2019
Figure Global Norditropin Sales Growth Rate (2017-2022)
Figure Global Norditropin Price (2017-2022)
Figure Global Genotropin Sales Growth Rate (2017-2022)
Figure Global Genotropin Price (2017-2022)
Figure Global Humatrope Sales Growth Rate (2017-2022)
Figure Global Humatrope Price (2017-2022)
Figure Global Saizen Sales Growth Rate (2017-2022)
Figure Global Saizen Price (2017-2022)
Figure Global Somatropin Biopartners Sales Growth Rate (2017-2022)
Table Global Growth Hormone Drug Sales by Big Application (2017-2022)
Table Global Growth Hormone Drug Sales Market Share by Big Application (2017-2022)
Figure Global Growth Hormone Drug Sales Market Share by Big Application in 2019
Figure Global Prader-Willi Syndrome Sales Growth Rate (2017-2022)
Figure Global Turner Syndrome Sales Growth Rate (2017-2022)
Figure Global Short Stature Homeobox Gene Sales Growth Rate (2017-2022)
Figure Global Small for Gestational Age Sales Growth Rate (2017-2022)
Figure Global Chronic Renal Insufficiency Sales Growth Rate (2017-2022)
Figure Global Short Bowel Syndrome Sales Growth Rate (2017-2022)
Figure Global Growth Hormone Drug Sales and Growth Rate (2022-2027)
Figure Global Growth Hormone Drug Revenue and Growth Rate (2022-2027)
Table Global Growth Hormone Drug Sales Forecast by Regions (2022-2027)
Table Global Growth Hormone Drug Market Share Forecast by Regions (2022-2027)
Figure North America Sales Growth Hormone Drug Market Forecast (2022-2027)
Figure Europe Sales Growth Hormone Drug Market Forecast (2022-2027)
Figure China Sales Growth Hormone Drug Market Forecast (2022-2027)
Figure Japan Sales Growth Hormone Drug Market Forecast (2022-2027)
Figure Southeast Asia Sales Growth Hormone Drug Market Forecast (2022-2027)
Figure Other Regions Sales Growth Hormone Drug Market Forecast (2022-2027)
Table Global Growth Hormone Drug Sales Forecast by Type (2022-2027)
Table Global Growth Hormone Drug Market Share Forecast by Type (2022-2027)
Table Global Growth Hormone Drug Sales Forecast by Application (2022-2027)
Table Global Growth Hormone Drug Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Growth Hormone Drug
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Growth Hormone Drug Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Growth Hormone Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Growth Hormone Drug Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Growth Hormone Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Growth Hormone Drug Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Growth Hormone Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Growth Hormone Drug Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Growth Hormone Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)